Combined Mechanism Glaucoma
When a chronic angle-closure component and an open-angle glaucoma component coexist in the same eye, addressing only one of the two is often not enough to fully control eye pressure.
Overview
Combined mechanism glaucoma describes an eye in which both a chronic angle-closure component and an open-angle glaucoma component are present at the same time. This can happen when a patient with anatomically narrow angles also has independent open-angle glaucoma risk factors, or when longstanding angle narrowing has caused lasting scarring (peripheral anterior synechiae) and trabecular meshwork damage that persists even after the acute angle-closure risk is addressed with a laser iridotomy.
The key clinical clue is eye pressure that remains elevated after a technically successful, patent laser iridotomy — a sign that pupillary block was not the only mechanism at play.
Symptoms
- Often none, especially if the angle-closure component was chronic rather than a sudden painful attack
- A history of a prior acute angle-closure attack, or a prior laser iridotomy performed for narrow angles
- Gradual peripheral vision loss if damage has progressed, similar to other glaucomas
- Occasionally intermittent blurred vision or discomfort if the angle remains partially crowded
How Common Is It?
Combined mechanism glaucoma is less common than pure primary open-angle glaucoma or pure primary angle-closure glaucoma, representing a distinct in-between category that becomes evident specifically when pressure doesn't normalize after addressing the angle-closure component.
It's more frequently recognized in patients of Asian or Inuit descent (who have a higher baseline rate of narrow angles) who also carry independent open-angle glaucoma risk factors, such as a family history of open-angle glaucoma.
Genetics & Risk Factors
Because this condition is essentially the overlap of two separate glaucoma processes, the relevant risk factors are the combination of both: anatomic risk factors for narrow angles (hyperopia, shorter eye length, Asian or Inuit ancestry, family history of angle closure) alongside separate risk factors for open-angle glaucoma (myopia, family history of open-angle glaucoma, thinner cornea, age).
A family history of either type of glaucoma is relevant and worth discussing at your evaluation.
Ocular Findings on Exam
After a laser iridotomy, gonioscopy may still show a crowded or only partially open angle, sometimes with visible peripheral anterior synechiae (permanent adhesions from prior angle narrowing) in areas that never fully opened even once the pupillary block was relieved.
The optic nerve may show cupping and damage consistent with either angle-closure or open-angle glaucoma, and visual field loss patterns don't reliably distinguish which mechanism is dominant on their own.
Testing & Diagnosis
- Gonioscopy performed after laser iridotomy to assess whether the angle is now fully open or remains crowded/scarred
- Anterior segment OCT imaging to evaluate angle configuration in detail
- Serial IOP measurements after iridotomy to confirm whether pressure has normalized
- OCT of the optic nerve fiber layer and visual field testing to assess cumulative damage
- Family and personal history covering both angle-closure and open-angle risk factors
Treatment Options
Laser Peripheral Iridotomy (First Step)
Relieves pupillary block and addresses the acute angle-closure risk; this is typically the first intervention if it hasn't already been performed.
Standard Open-Angle Glaucoma Drops
Used for the residual pressure elevation that persists after iridotomy, following the same medication classes used in primary open-angle glaucoma.
Cataract Surgery
Removing the natural lens can further deepen and open the drainage angle in some patients, which may meaningfully improve the angle-closure component, though it does not resolve a separate open-angle component on its own.
Laser Trabeculoplasty or Glaucoma Surgery
If drops aren't sufficient to control the residual open-angle component, laser trabeculoplasty or incisional glaucoma surgery is used, just as it would be in primary open-angle glaucoma.
How This Differs From Other Glaucomas
Unlike pure angle-closure glaucoma, where a laser iridotomy is often definitive, combined mechanism glaucoma requires ongoing open-angle-style management even after the iridotomy is successfully performed, because part of the pressure problem was never caused by pupillary block in the first place.
And unlike pure open-angle glaucoma, the angle anatomy itself must be addressed first (with iridotomy, and sometimes cataract surgery) before the remaining open-angle component can be accurately assessed and treated — making the sequencing of treatment, not just the treatment choices themselves, a distinguishing feature of managing this condition.
Frequently Asked Questions
I already had a laser iridotomy — why is my pressure still high?
A laser iridotomy relieves pupillary block, the main mechanism behind acute angle closure, but if there is also an underlying open-angle glaucoma component (or lasting scarring in the angle from prior narrowing), pressure can remain elevated even after a successful, patent iridotomy.
Is this common?
It's a recognized but less common category compared to pure angle-closure or pure open-angle glaucoma, seen when both sets of risk factors and mechanisms are present in the same eye.
Will cataract surgery help?
Sometimes. Removing the natural lens (during cataract surgery) can further open and deepen the drainage angle in some patients, which may reduce the angle-closure component and improve pressure control, though it does not address any separate open-angle component.
Do I need surgery beyond the iridotomy?
Possibly. If drops aren't sufficient to control the residual open-angle component after iridotomy, laser trabeculoplasty or incisional glaucoma surgery may be recommended, following the same general approach used for open-angle glaucoma.
See a glaucoma specialist. Dr. Robert Gunzenhauser is Harvard-educated and UCLA fellowship-trained in glaucoma, providing expert diagnosis and treatment for Combined Mechanism Glaucoma at Inland Glaucoma Center in Upland, CA.